• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩散具有方向性:创新的扩散张量成像技术可改善前列腺癌检测。

Diffusion Is Directional: Innovative Diffusion Tensor Imaging to Improve Prostate Cancer Detection.

作者信息

Shenhar Chen, Degani Hadassa, Ber Yaara, Baniel Jack, Tamir Shlomit, Benjaminov Ofer, Rosen Philip, Furman-Haran Edna, Margel David

机构信息

Department of Urology, Rabin Medical Center, 39 Ze'ev Jabotinsky St, Petah Tikva 4941492, Israel.

Department of Biological Regulation, Weizmann Institute of Science, Rehovot 7610001, Israel.

出版信息

Diagnostics (Basel). 2021 Mar 20;11(3):563. doi: 10.3390/diagnostics11030563.

DOI:10.3390/diagnostics11030563
PMID:33804783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003841/
Abstract

In the prostate, water diffusion is faster when moving parallel to duct and gland walls than when moving perpendicular to them, but these data are not currently utilized in multiparametric magnetic resonance imaging (mpMRI) for prostate cancer (PCa) detection. Diffusion tensor imaging (DTI) can quantify the directional diffusion of water in tissue and is applied in brain and breast imaging. Our aim was to determine whether DTI may improve PCa detection. We scanned patients undergoing mpMRI for suspected PCa with a DTI sequence. We calculated diffusion metrics from DTI and diffusion weighted imaging (DWI) for suspected lesions and normal-appearing prostate tissue, using specialized software for DTI analysis, and compared predictive values for PCa in targeted biopsies, performed when clinically indicated. DTI scans were performed on 78 patients, 42 underwent biopsy and 16 were diagnosed with PCa. The median age was 62 (IQR 54.4-68.4), and PSA 4.8 (IQR 1.3-10.7) ng/mL. DTI metrics distinguished PCa lesions from normal tissue. The prime diffusion coefficient (λ) was lower in both peripheral-zone ( < 0.0001) and central-gland ( < 0.0001) cancers, compared to normal tissue. DTI had higher negative and positive predictive values than mpMRI to predict PCa (positive predictive value (PPV) 77.8% (58.6-97.0%), negative predictive value (NPV) 91.7% (80.6-100%) vs. PPV 46.7% (28.8-64.5%), NPV 83.3% (62.3-100%)). We conclude from this pilot study that DTI combined with T2-weighted imaging may have the potential to improve PCa detection without requiring contrast injection.

摘要

在前列腺中,水沿导管和腺壁平行方向扩散的速度比垂直方向更快,但目前这些数据尚未用于多参数磁共振成像(mpMRI)检测前列腺癌(PCa)。扩散张量成像(DTI)可以量化组织中水分子的扩散方向,已应用于脑部和乳腺成像。我们的目的是确定DTI是否能提高PCa的检测能力。我们对疑似PCa且正在接受mpMRI检查的患者进行了DTI序列扫描。我们使用专门的DTI分析软件,计算了疑似病变和外观正常的前列腺组织的DTI和扩散加权成像(DWI)的扩散指标,并比较了临床指征明确时靶向活检中PCa的预测值。对78例患者进行了DTI扫描,其中42例接受了活检,16例被诊断为PCa。中位年龄为62岁(四分位间距54.4 - 68.4),前列腺特异性抗原(PSA)为4.8(四分位间距1.3 - 10.7)ng/mL。DTI指标能够区分PCa病变和正常组织。与正常组织相比,外周区(<0.0001)和中央腺体(<0.0001)癌的表观扩散系数(λ)均较低。在预测PCa方面,DTI的阴性和阳性预测值高于mpMRI(阳性预测值(PPV)77.8%(58.6 - 97.0%),阴性预测值(NPV)91.7%(80.6 - 100%),而mpMRI的PPV为46.7%(28.8 - 64.5%),NPV为83.3%(62.3 - 100%))。我们从这项初步研究得出结论,DTI联合T2加权成像可能有潜力在无需注射造影剂的情况下提高PCa的检测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/a9a533e61655/diagnostics-11-00563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/0bf191cff06f/diagnostics-11-00563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/84430a712922/diagnostics-11-00563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/a9a533e61655/diagnostics-11-00563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/0bf191cff06f/diagnostics-11-00563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/84430a712922/diagnostics-11-00563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bf/8003841/a9a533e61655/diagnostics-11-00563-g003.jpg

相似文献

1
Diffusion Is Directional: Innovative Diffusion Tensor Imaging to Improve Prostate Cancer Detection.扩散具有方向性:创新的扩散张量成像技术可改善前列腺癌检测。
Diagnostics (Basel). 2021 Mar 20;11(3):563. doi: 10.3390/diagnostics11030563.
2
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.多参数磁共振成像在前列腺穿刺活检中排除前列腺癌的阴性预测值是多少?来自欧洲泌尿外科学会前列腺癌指南小组的系统评价和荟萃分析。
Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21.
3
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.多参数磁共振成像能否检测到有临床意义的前列腺癌?文献系统评价。
Eur Urol. 2015 Dec;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. Epub 2015 Feb 2.
4
Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.扩散峰度成像与标准扩散成像在周围区前列腺癌检测及分级中的评估
Invest Radiol. 2015 Aug;50(8):483-9. doi: 10.1097/RLI.0000000000000155.
5
Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.基于多参数 MRI 的活检前风险评分在前列腺特异性抗原 4-10ng/ml 的前列腺活检初筛男性中预测前列腺癌的价值
J Magn Reson Imaging. 2018 May;47(5):1227-1236. doi: 10.1002/jmri.25850. Epub 2017 Sep 4.
6
Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?3特斯拉盆腔相控阵多参数磁共振成像能否避免血清前列腺特异抗原(PSA)<10 ng/mL患者进行不必要的重复前列腺穿刺活检?
Clin Genitourin Cancer. 2015 Feb;13(1):e27-30. doi: 10.1016/j.clgc.2014.06.013. Epub 2014 Jun 21.
7
Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.前列腺多参数磁共振成像(mpMRI)的欧洲泌尿生殖放射学会(ESUR)标准化评分系统的组织学核心特定评估。
BJU Int. 2013 Dec;112(8):1080-7. doi: 10.1111/bju.12259. Epub 2013 Aug 13.
8
Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.在多参数磁共振成像上具有临床显著意义的前列腺癌患者中检测 Gleason 6 前列腺癌。
Clin Hemorheol Microcirc. 2019;73(1):105-111. doi: 10.3233/CH-199223.
9
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.多参数磁共振成像作为高度疑似前列腺癌男性的一线工具的临床实用性。
Eur Urol Oncol. 2018 Aug;1(3):208-214. doi: 10.1016/j.euo.2018.03.008. Epub 2018 May 15.
10
Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.接受主动监测的男性患者的确诊活检:扩大穿刺活检与饱和穿刺活检对比多参数磁共振成像/经直肠超声融合前列腺穿刺活检
Scand J Urol. 2017 Aug;51(4):260-263. doi: 10.1080/21681805.2017.1313310. Epub 2017 May 17.

引用本文的文献

1
Comparative Analysis of the Apparent Diffusion Coefficient and Diffusion Tensor Imaging in the Diagnosis of Prostate Cancer.对比分析表观扩散系数与扩散张量成像在前列腺癌诊断中的应用。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2397-2408. doi: 10.31557/APJCP.2024.25.7.2397.
2
Diffusion tensor imaging and fiber tractography of the normal epididymis.正常附睾的弥散张量成像和纤维束追踪技术。
Abdom Radiol (NY). 2024 Aug;49(8):2932-2941. doi: 10.1007/s00261-024-04372-y. Epub 2024 Jun 5.
3
Multiparametric MRI for characterization of the tumour microenvironment.

本文引用的文献

1
Characterization of prostate cancer using diffusion tensor imaging: A new perspective.使用扩散张量成像对前列腺癌进行特征描述:新视角。
Eur J Radiol. 2019 Jan;110:112-120. doi: 10.1016/j.ejrad.2018.11.026. Epub 2018 Nov 22.
2
Detection of high GS risk group prostate tumors by diffusion tensor imaging and logistic regression modelling.通过扩散张量成像和逻辑回归模型检测高GS风险组前列腺肿瘤
Magn Reson Imaging. 2018 Jul;50:125-133. doi: 10.1016/j.mri.2018.04.003. Epub 2018 Apr 9.
3
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
多参数 MRI 用于肿瘤微环境的特征分析。
Nat Rev Clin Oncol. 2024 Jun;21(6):428-448. doi: 10.1038/s41571-024-00891-1. Epub 2024 Apr 19.
4
Acquisition Parameters Influence Diffusion Metrics Effectiveness in Probing Prostate Tumor and Age-Related Microstructure.采集参数对扩散指标探测前列腺肿瘤及与年龄相关微观结构的有效性有影响。
J Pers Med. 2023 May 20;13(5):860. doi: 10.3390/jpm13050860.
5
Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.血清有机酸代谢物可作为潜在的生物标志物,用于识别前列腺炎、良性前列腺增生和前列腺癌。
Front Immunol. 2023 Jan 4;13:998447. doi: 10.3389/fimmu.2022.998447. eCollection 2022.
6
Diffusion and quantification of diffusion of prostate cancer.前列腺癌的扩散与定量分析。
Br J Radiol. 2022 Mar 1;95(1131):20210653. doi: 10.1259/bjr.20210653. Epub 2021 Sep 19.
MRI 靶向或标准活检用于前列腺癌诊断。
N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18.
4
Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.高级扩散加权成像模型在前列腺癌特征描述中的应用:与定量组织病理学肿瘤组织成分的相关性——一项假说生成研究。
Radiology. 2018 Mar;286(3):918-928. doi: 10.1148/radiol.2017170904. Epub 2017 Nov 8.
5
Evaluation of Peripheral Zone Prostate Cancer Aggressiveness Using the Ratio of Diffusion Tensor Imaging Measures.应用弥散张量成像测量比值评估外周带前列腺癌侵袭性。
Contrast Media Mol Imaging. 2017 Sep 26;2017:5678350. doi: 10.1155/2017/5678350. eCollection 2017.
6
Time-Dependent Diffusion in Prostate Cancer.前列腺癌中的时变弥散。
Invest Radiol. 2017 Jul;52(7):405-411. doi: 10.1097/RLI.0000000000000356.
7
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.多参数 MRI 和 TRUS 活检在前列腺癌(PROMIS)中的诊断准确性:一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
8
Diffusion tensor imaging in abdominal organs.腹部器官的扩散张量成像
NMR Biomed. 2017 Mar;30(3). doi: 10.1002/nbm.3434. Epub 2015 Nov 11.
9
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.PI-RADS前列腺影像报告和数据系统:2015版,第2版
Eur Urol. 2016 Jan;69(1):16-40. doi: 10.1016/j.eururo.2015.08.052. Epub 2015 Oct 1.
10
False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance.多参数前列腺磁共振成像在前列腺癌主动监测中的假阳性和假阴性诊断
Insights Imaging. 2015 Aug;6(4):449-63. doi: 10.1007/s13244-015-0411-3. Epub 2015 May 23.